Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing.
about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyNeuroprotective Activity of Hypericum perforatum and Its Major ComponentsEmerging drug targets for Aβ and tau in Alzheimer's disease: a systematic reviewIs L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type miceTetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent AutophagyReduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.A novel recombinant 6Aβ15-THc-C chimeric vaccine (rCV02) mitigates Alzheimer's disease-like pathology, cognitive decline and synaptic loss in aged 3 × Tg-AD mice.Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model.Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells.Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapyTetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease.Chronic hypoxia induces the activation of the Wnt/β-catenin signaling pathway and stimulates hippocampal neurogenesis in wild-type and APPswe-PS1ΔE9 transgenic mice in vivo.Canonical Wnt signaling protects hippocampal neurons from Aβ oligomers: role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics.Andrographolide Stimulates Neurogenesis in the Adult Hippocampus.Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice.Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo.Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.TRPC Channels and Alzheimer's Disease.Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer's Disease.Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
P2860
Q21129335-F2A865AC-2AC5-4FC3-AF7E-79535E5B53DDQ26382049-0893D8D9-1B24-4540-8248-B40980E3FF95Q26741405-70D486B0-C4A1-406E-83E9-81A2E910DF8CQ27024232-D75A371C-7715-4275-A286-17F660725232Q27301311-797BAC4E-2B72-48B3-AEB2-A71FB3EABD26Q28547501-4ADA6DAC-51DD-4D4F-885A-5C54D2BA6EF1Q34380018-CF61DD95-EF1C-4969-BE1B-FD4992B9DAE1Q36964826-C55EC355-5079-4AFD-BA6D-2D609E174AB2Q37445085-C8830A36-DFA1-488D-A15F-668D42F029E0Q37688368-AB2E2056-C256-449A-9710-2004BC88E960Q38958106-AB6A44FC-0A72-4807-9C89-72E3621D61D4Q39038529-4652E21E-48BE-489F-A424-5B14D3664F98Q39613214-F6BF7A42-677F-41CC-B71C-571DA82068DDQ40445320-291F8858-61FB-4599-B63B-6C0E5FB38644Q41849989-B2CF8CA1-D65A-43E7-A3F0-666A2D7817FBQ43031899-79159C61-C8A8-47CE-BC88-249847A72B20Q43106553-60CF255A-4C44-4A81-B7D4-BBF7A9CAFF66Q47098610-80D6C7A0-0701-4718-9857-210F8D0FE911Q48145375-9173E1F1-803F-4647-95FE-92CD21C6B2ABQ48284096-FDCD26D9-DEA9-4A81-9DD6-4CEA554A2163Q48447516-20C86D54-BAEB-411D-8BE2-8BA6FE6B24FAQ50023771-76759B91-44C7-4664-84FE-A59C4F0DCDEFQ50999462-2935A394-6459-4D65-8B51-F69059618D0FQ55231947-468F803E-70C1-417E-A0BC-CF1C1FC19134Q57131389-EE51ADEF-2F97-4627-9DC8-1DEECFD4BA3C
P2860
Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@en
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@nl
type
label
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@en
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@nl
prefLabel
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@en
Tetrahydrohyperforin prevents ...... ible effect on APP processing.
@nl
P2093
P2860
P50
P356
P1476
Tetrahydrohyperforin prevents ...... sible effect on APP processing
@en
P2093
A R Alvarez
A Rivera-Dictter
C Tapia-Rojas
F J Carvajal
J L Hancke
M J Benito
N C Inestrosa
P V Burgos
T N Griffith
P2860
P2888
P356
10.1038/TP.2011.19
P577
2011-07-12T00:00:00Z